Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemic diseases.
ALDX | US
Overview
Corporate Details
- ISIN(s):
- US01438T1060
- LEI:
- Country:
- United States of America
- Address:
- 131 HARTWELL AVENUE, 2421 LEXINGTON
- Website:
- https://www.aldeyra.com/
- Sector:
- Manufacturing
Description
Aldeyra Therapeutics is a biotechnology company developing medications for immune-mediated diseases. The company's therapeutic approach involves modulating immunological systems rather than inhibiting or activating single protein targets, with the goal of optimizing multiple pathways while minimizing toxicity. Its portfolio of product candidates targets inflammatory cells associated with both ocular and systemic ailments. Aldeyra has investigational therapies in late-stage clinical development for conditions such as dry eye disease and allergic conjunctivitis, aiming to address medical needs not adequately met by existing treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Aldeyra Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Aldeyra Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Aldeyra Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
